JACKSONVILLE, Fla., March 27, 2026 /PRNewswire/ -- BionicM USA LLC and Brooks Rehabilitation have announced a collaborative clinical research study, titled Adaptive Mobility Technology: A Comparative ...
Comparison of response from RECIST1.1 and abstraction in real-world patients with lung cancer. Background: The outcomes in advanced non-small cell lung cancer (NSCLC) have improved due to the ...
Primary endpoint of Overall Response Rate at Week 18 met, demonstrating clinical equivalence in patients with advanced ...
The comparative effectiveness of glucose-lowering medications for use with metformin to maintain target glycated hemoglobin levels in persons with type 2 diabetes is uncertain. In this trial involving ...
Correspondence to Dr Parco M Siu, The University of Hong Kong, Hong Kong, 999077, Hong Kong; pmsiu{at}hku.hk Data sources Embase, MEDLINE, PsycINFO, Cochrane Library, Web of Science, Scopus and ...
RAAS inhibitors outperform CCBs in paediatric CKD, lowering kidney failure risk. Discover how this real-world study could ...
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health ...
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study We divided the borrowing ...
The messenger RNA (mRNA)–based vaccines BNT162b2 and mRNA-1273 are more than 90% effective against coronavirus disease 2019 (Covid-19). However, their comparative effectiveness for a range of outcomes ...
Drugs like semaglutide, the active ingredient of Ozempic and Wegovy, are more effective in treating type 2 diabetes than conventional treatments, a comprehensive new comparative study finds. About one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results